Bolt Biotherapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, June 24, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Bolt Biotherapeutics, Inc. ("Bolt" or the "Company") (NASDAQ: BOLT) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors. Bolt investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq. Investors are encouraged to contact attorn ...